Thomas Fleming
Heidelberg University(DE)University Hospital Heidelberg(DE)Helmholtz Zentrum München(DE)Max Planck Institute for the Science of Light(DE)Deutsches Diabetes-Zentrum e.V.(DE)German Center for Diabetes Research(DE)Heinrich Heine University Düsseldorf(DE)
Publications by Year
Research Areas
Advanced Glycation End Products research, Pain Mechanisms and Treatments, Biochemical effects in animals, Diabetes, Cardiovascular Risks, and Lipoproteins, Diet and metabolism studies
Most-Cited Works
- → Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2(2001)11,439 cited
- → Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy(2012)489 cited
- → DAMP Signaling is a Key Pathway Inducing Immune Modulation after Brain Injury(2015)320 cited
- → C. elegans as Model for the Study of High Glucose– Mediated Life Span Reduction(2009)295 cited
- → Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark(2018)253 cited
- → Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention(2017)197 cited